Connecting you to content on EBSCOhost

Works matching AU Oren, Shirly

Results: 6

1

A Cross-sectional Survey on the Preference of Patients with Rheumatoid Arthritis for Route of Administration of Disease-Modifying Anti-Rheumatic Drugs: Oral Target-Specific Versus Parenteral Biologic.

Published in:

Israel Medical Association Journal, 2020, v. 22, n. 3, p. 154

By:

Edel, Yonatan;
Sagy, Iftach;
Pokroy-Shapira, Elisheva;
Oren, Shirly;
Lazar, Ariela Dortort;
Egbaria, Mohammad;
Shiber, Shachaf;
Tal, Bat Sheva;
Molad, Yair

Publication type:

Article

2

Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti- CCP-positive, early rheumatoid arthritis.

Published in:

European Journal of Clinical Investigation, 2015, v. 45, n. 6, p. 557, doi. 10.1111/eci.12442

By:

Molad, Yair;
Ofer‐Shiber, Shachaf;
Pokroy‐Shapira, Elisheva;
Oren, Shirly;
Shay‐Aharoni, Hagit;
Babai, Ilan

Publication type:

Article

3

Guanine polynucleotides are self-antigens for human natural autoantibodies and are significantly reduced in the human genome.

Published in:

Immunology, 2015, v. 146, n. 3, p. 401, doi. 10.1111/imm.12514

By:

Fattal, Ittai;
Shental, Noam;
Ben‐Dor, Shifra;
Molad, Yair;
Gabrielli, Armando;
Pokroy‐Shapira, Elisheva;
Oren, Shirly;
Livneh, Avi;
Langevitz, Pnina;
Zandman‐Goddard, Gisele;
Sarig, Ofer;
Margalit, Raanan;
Gafter, Uzi;
Domany, Eytan;
Cohen, Irun R.

Publication type:

Article

4

Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti- DNA.

Published in:

Immunology, 2014, v. 141, n. 2, p. 276, doi. 10.1111/imm.12200

By:

Fattal, Ittai;
Shental, Noam;
Molad, Yair;
Gabrielli, Armando;
Pokroy‐Shapira, Elisheva;
Oren, Shirly;
Livneh, Avi;
Langevitz, Pnina;
Pauzner, Rachel;
Sarig, Ofer;
Gafter, Uzi;
Domany, Eytan;
Cohen, Irun R.

Publication type:

Article

5

A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.

Published in:

Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1064839

By:

Kharouf, Fadi;
Eviatar, Tali;
Braun, Maya;
Pokroy-Shapira, Elisheva;
Brodavka, Michal;
Zloof, Yair;
Agmon-Levin, Nancy;
Toledano, Kochava;
Oren, Shirly;
Lidar, Merav;
Zisman, Devy;
Tavor, Yonit;
Amit-Vazina, Mirit;
Sabbah, Firas;
Breuer, Gabriel S.;
Dagan, Amir;
Beshara-Garzuzi, Rima;
Markovits, Doron;
Elias, Muna;
Feld, Joy

Publication type:

Article

6

Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome.

Published in:

Arthritis Research & Therapy, 2019, v. 21, n. 1, p. 1, doi. 10.1186/s13075-018-1779-5

By:

Edel, Yonatan;
Kliminski, Vitaly;
Pokroy-Shapira, Elisheva;
Oren, Shirly;
Lazar, Ariela Dortort;
Basson, Yael Pri-Paz;
Egbaria, Mohammad;
Molad, Yair

Publication type:

Article